Back to Trades
Robins Jason Shand
Chief Financial OfficerCIK 0002104600
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 3
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 3 filings between 2026, Robins Jason Shand, Chief Financial Officer, has disclosed $500.4K in transactions — all concentrated in OCULAR THERAPEUTIX, INC (OCUL). Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Jun 12 | OCUL OCULAR THERAPEUTIX, INC | Robins Jason Shand | Chief Financial Officer | Grant | $122.6K |
| Jan 22 | OCUL OCULAR THERAPEUTIX, INC | Robins Jason Shand | Interim CFO | Other | $0 |
| Jan 22 | OCUL OCULAR THERAPEUTIX, INC | Robins Jason Shand | Interim CFO | Award | $377.9K |
3 filings